Author:
McClaskey John,Xu Mina,Snyder Edward L.,Tormey Christopher A.
Reference69 articles.
1. FDA approach to evaluation of pathogen reduction technology;Epstein;Transfusion,2003
2. Properties of pathogen-inactivated plasma components;Prowse;Transfus Med Rev,2009
3. Pathogen inactivation techniques;Pelletier;Best Pract Res Clin Haematol,2006
4. Update on pathogen reduction technology for therapeutic plasma: an overview;Solheim;Transfus Apher Sci,2006
5. Octapharma. octaplas® Australian Approved Product Information Sheet (PI). [accessed 29.06.09].
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献